The Drug Science Podcast

{{ show.title }}Trailer Bonus Episode {{ selectedEpisode.number }}
{{ selectedEpisode.title }}
|
{{ selectedEpisode.title }}
By {{ selectedEpisode.author }}
Broadcast by

Dr Peter Gasser is one of the 15-20 Swiss psychiatrists that are legally allowed to prescribe LSD/MDMA-assisted psychotherapy outside of clinical research.

Show Notes

Today’s episode features Dr Peter Gasser, the president of the Swiss Medical Society for Psycholytic Therapy.
 
Professor Nutt and Dr Gasser talk about the rather unusual and innovative attitude to psychedelic research in Switzerland. 
 
How can Britain learn from the Swiss? What are the drug policies in the Albert Hofmann’s - the discoverer of LSD - country?
 
Dr Peter Gasser is a Swiss psychiatrist and psychotherapist and the President of the Swiss Medical Society for Psycholytic Therapy since 1997. After LSD was criminalized worldwide he was the first person to conduct research on psychedelic-assisted psychotherapy. Additionally, he holds a permission for and provides treatment using MDMA and LSD.
 
MDMA

LSD

Swiss Medical Society for Psycholytic Therapy

International Symposium on the Occasion of the 100th Birthday of Albert Hofmann

Albert Hofmann

Psilocybin

Post-traumatic stress disorder

MAPS - Multidisciplinary Association for Psychedelic Studies

War on drugs - US political campaign 

The Psychedelic Renaissance

Pilot study on LSD-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

End of life anxiety 

Obsessive-compulsive disorder

Cluster headache

Psycholytic therapy with MDMA and LSD in Switzerland - MAPS article 

★ Support this podcast ★

What is The Drug Science Podcast?

Professor David Nutt has spent a career making the argument for a rational, evidence-based approach to drug policy and drug use. The scientific evidence still challenges perceived wisdom on drugs and for that reason can appear to be contentious. In this podcast, the Professor explores the actual harms and potential benefits of various drugs, challenging myths surrounding classification and legislation, and exploring the societal impact of poorly informed drug policy. Using evidence in public policy should not be controversial. A podcast for anyone interested in understanding the scientific truth about drugs, free from political or moral concern.